Skip to main content
Market icon

4月30日までに米国ではしかの症例がありますか？

Market icon

4月30日までに米国ではしかの症例がありますか？

4月 30

12月 31

4月 30

12月 31

Polymarket

$218,214 Vol.

Polymarket

$218,214 Vol.

1750

$691 Vol.

100%

1800

$66,161 Vol.

42%

1900

$51,984 Vol.

3%

1850

$8,719 Vol.

6%

2000

$43,089 Vol.

2%

1950

$21,551 Vol.

2%

2100

$9,405 Vol.

1%

2200

$16,613 Vol.

1%

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.The Centers for Disease Control and Prevention (CDC) reports 1,748 confirmed measles cases in the United States for 2026 as of April 16, across 33 jurisdictions with 94% outbreak-associated, mainly among unvaccinated persons amid declining MMR coverage at 92.5% for kindergartners. Recent developments show slowing growth, with smaller weekly increases following public health responses in hotspots like South Carolina, Utah, and Texas, driving trader consensus toward minimal additional cases before April 30 resolution based on the CDC case counter. Inherent reporting lags and potential new clusters introduce uncertainty; the next CDC Thursday update on April 24 will offer critical data on transmission dynamics.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
音量
$218,214
終了日
2026/04/30
マーケット開始日
Apr 16, 2026, 10:34 AM ET

Resolver

0x65070BE91...
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.The Centers for Disease Control and Prevention (CDC) reports 1,748 confirmed measles cases in the United States for 2026 as of April 16, across 33 jurisdictions with 94% outbreak-associated, mainly among unvaccinated persons amid declining MMR coverage at 92.5% for kindergartners. Recent developments show slowing growth, with smaller weekly increases following public health responses in hotspots like South Carolina, Utah, and Texas, driving trader consensus toward minimal additional cases before April 30 resolution based on the CDC case counter. Inherent reporting lags and potential new clusters introduce uncertainty; the next CDC Thursday update on April 24 will offer critical data on transmission dynamics.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
音量
$218,214
終了日
2026/04/30
マーケット開始日
Apr 16, 2026, 10:34 AM ET

Resolver

0x65070BE91...
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.

外部リンクに注意してください。

よくある質問

「4月30日までに米国ではしかの症例がありますか？」はPolymarket上の8個の結果が可能な予測市場で、トレーダーが何が起こるかに基づいてシェアを売買します。現在のリード結果は「1750」で100%、次いで「1800」が42%です。価格はコミュニティのリアルタイム確率を反映しています。例えば、100¢で取引されているシェアは、市場がその結果に100%の確率を集合的に割り当てていることを意味します。これらのオッズは継続的に変化します。正しい結果のシェアは市場決済時に各$1で引き換え可能です。

本日現在、「4月30日までに米国ではしかの症例がありますか？」は$218.2Kの総取引量を生み出しています（Mar 24, 2026のマーケット開始以来）。この取引活動レベルはPolymarketコミュニティの強い関与を反映し、現在のオッズが幅広い市場参加者によって形成されていることを保証します。このページで直接、ライブの価格変動を追跡し、任意の結果で取引できます。

「4月30日までに米国ではしかの症例がありますか？」で取引するには、このページに記載されている8個の利用可能な結果を閲覧します。各結果には市場の暗示確率を表す現在の価格が表示されています。ポジションを取るには、最も可能性が高いと思う結果を選び、「はい」で支持するか「いいえ」で反対するかを選択し、金額を入力して「取引」をクリックします。選んだ結果が市場決済時に正しければ、「はい」のシェアは各$1を支払います。正しくなければ$0です。決済前にいつでもシェアを売却できます。

「4月30日までに米国ではしかの症例がありますか？」の現在のフロントランナーは「1750」で100%であり、市場がこの結果に100%の確率を割り当てていることを意味します。次に近い結果は「1800」で42%です。これらのオッズはトレーダーがシェアを売買するにつれてリアルタイムで更新されます。頻繁に確認するか、このページをブックマークしてください。

「4月30日までに米国ではしかの症例がありますか？」の決済ルールは、各結果が勝者と宣言されるために何が起こる必要があるかを正確に定義しています。これには結果を決定するために使用される公式データソースも含まれます。このページのコメント上にある「ルール」セクションで完全な決済基準を確認できます。取引前にルールを注意深く読むことをお勧めします。